National Bank of Canada’s Celularity CELU Stock Holding History

National Bank of Canada’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-48,000	Closed	-$83K	–	3031
2025 Q1	$83K	Buy	+48,000	New	+$90.9K	﹤0.01%	1745

Other funds holding CELU

CVSC

C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

YAG

Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Valmark Advisers Akron, Ohio $9.42B AUM 17.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

National Bank of Canada's CELU Position: Q2 2025 in Review

National Bank of Canada sold out of Celularity (CELU) in Q2 2025, closing a stake of 48,000 shares — an estimated $83K sold.

National Bank of Canada first reported a position in CELU in Q1 2025 and held it in 1 quarter. The position peaked at $83K in Q1 2025. 34 funds tracked by Wall St. Rank hold CELU as of Q2 2025.

National Bank of Canada reported no remaining Celularity position as of Q2 2025 after selling out during the quarter.
National Bank of Canada sold 48,000 Celularity shares in Q2 2025, an estimated $83K.
National Bank of Canada first reported a position in Celularity in Q1 2025 and held it in 1 quarter.
National Bank of Canada's Celularity position peaked at $83K in Q1 2025.
34 funds tracked by Wall St. Rank held Celularity as of Q2 2025.

Based on National Bank of Canada's 13F filing for Q2 2025, filed 13 Aug 2025.